drugset / Trial / NCT01587508
Study Comparing A New Drug Containing The Combination Meloxicam And Cyclobenzaprine In The Treatment Of Acute Lumbago
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to assess the efficacy end tolerability of a new drug containing the combination meloxicam and cyclobenzaprine (7,5/10mg) and the same components alone in the treatment of acute lumbago.
Timeline
- Start
- 2013-05
- Primary completion
- 2013-05
- Completion
- 2013-05
Outcome
Outcome not reported
Stopped: “The comparator product was withdrawn from the brazilian market not being possible to conduct the design regarding initially planned.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Meloxicam | Small molecule | 7.5 mg | Oral |
| Comparator | cyclobenzaprine | Unknown | 10 mg | Oral |
Indications
No indication recorded.